Hi Glyco,
I touched base with Dr Yacov yesterday with 2 emails and got a reply straight away. He is also feeling the pain of what we are currently going through, but I suggested that these performance based shares need to be justified, as the SP is definitely not showing it. The SH's are angry that the company has the gall to even put this up for approval.
I voted "no" for well over 1 million shares. It is frustrating what has happened with the SP with the announcement over the past few months. I thought that the big announcement when we got the FDA approval was the one to get us going, especially when we went from $0.045 upto $0.16. I had been hanging on for so long thinking Yes! finally what we have been waiting for to kick start the big climb back to mid $0.30's, but no, unfortunately we went back down.
I'm not quite sure what Dr G has in his big bag of tricks, but it better be revenue, revenue and more revenue. The only significant announcement would be the NMPA approval and the China factory coming onboard. Hopefully if we see a large PO, it would possibly be the start of a rerating.
I'm not too sure what Dr G meant when he said "one day and not too far you will enjoy your investment"
I haven't given up on GMV because I still think that GMV will be a global company but I'm not sure how long the company can continue without significant revenue. They can't keep draining the coffers at these low prices.
Everyone who has been on HC would know that I have been a proactive supporter of Dr G and his team, but this audacious move to lock in Performance based shares is a smack in the cheek and goes against what Australian SH's believe in.
I hope we come out of this smelling of roses, because I know alot of the LT holders have a significant amount of shares invested in the company and more than likely an average probably close to $0.18.
DYOR GLTAH
Cheers Rubes
Dr Yacov' s response to my emails,
Thank you for your support! One day and not too far you will enjoy your investment!!!
Sent from my iPhone
On 19 Jun 2020, at 8:44, mni99504 wrote:
Hi Dr Yacov,
Thankyou for your reply. I know you have spent alot of money in this company and that is why I have been in your corner (I still am) since the very start. I believe in your vision and strategy moving forward however this China NMPA approval has certainly
weighed the company down to the extent that the positive news for the FDA USA announcements has the company back at $0.05 level.
My heart goes out to you Dr G as I know alot of this is out of your control and you are just as frustrated as the SH's are. I'm not sure if you could reduce the amount of performance shares being allocated, but at the moment there are alot of disappointed SH's saying that due to the current share price, why should any director's recieve bonuses, it just dosen't sit right. I applaud what your vision and goals are and I know that this is a long term project, that is why I believe in what you represent and I'm still in yourcorner.
Thankyou Malcolm Nicholls
Sent from Samsung tablet.
-------- Original message --------
From: Yacov Geva
Date: 19/6/20 3:19 pm (GMT+10:00)
To: mni99504 Subject: Re: AGM I am only asked for performance! Secondly I have invested $12M US and continue and you should look on the company long term . The share price is not in my control !!!
Sent from my iPhone
On 19 Jun 2020, at 7:41, mni99504 wrote:
Hi Dr Yacov,
I'm writing this email because of the proposed allocation of shares to be issued in the upcoming AGM. Let me tell you that it has not been accepted positively and you need to sugar coat it somehow.
I have been a staunch supporter of you for the past 3 years, but this allocation of shares to be voted on, has really made me angry. GMV's performance over the last 6mths has been a disaster, even though we have had promising announcements, this has
never been backed up with PO's and the market has reacted by punishing the company.
I have alot of money invested with you because I believe in the company's products which is the way of the future. I hope you have another rabbit to pull out of the hat because the company really needs it badly.
Cheers Malcolm Nicholls,
Expand
